Serial Number | 97296211 |
Word Mark | CELERNA |
Filing Date | Friday, March 4, 2022 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, October 30, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, January 31, 2023 |
Goods and Services | Research and development in the fields of pharmaceuticals, therapeutics, and biologics, namely, exosome-based delivery systems for pharmaceuticals, therapeutics, and biologics; Medical research and development in the field of molecular biology, genetic engineering, drug delivery, and bioinformatics; Research and development of delivery systems for therapeutic compounds, namely, exosome-based drug delivery systems for therapeutic compounds for the treatment of viral pathogens, cancer and inherited disorder in humans; Research and development of delivery systems for therapeutic compounds, namely, exosome-based drug delivery of therapeutic compounds; Research and development of delivery systems for therapeutic nucleic acids, namely, exosome-based drug delivery of therapeutic nucleic acids, namely, RNA; Research and development of delivery systems for therapeutic peptides, namely, exosome-based drug delivery of therapeutic peptides; Research and development of delivery systems for gene-editing proteins, namely, exosome-based drug delivery of gene-editing proteins; Research and development of delivery systems for vaccines, namely, exosome-based drug delivery systems for vaccines; Research and development of the production of exosomes for therapeutic uses, namely, yeast-based exosome for therapeutic uses; Research and development of new biological products for therapeutic use; Design and development of nucleic acids, proteins, enzymes, and drug compounds for use in pharmaceuticals, biotechnology, medical, and diagnostic applications |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, March 9, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Spartina Biotechnologies, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Santa Fe, NM 87507 |
Party Name | Spartina Biotechnologies, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Santa Fe, NM 87507 |
Event Date | Event Description |
Monday, October 30, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Monday, October 30, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
Tuesday, March 28, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, January 31, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, January 31, 2023 | PUBLISHED FOR OPPOSITION |
Wednesday, January 11, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Thursday, December 29, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, December 15, 2022 | ASSIGNED TO EXAMINER |
Wednesday, March 9, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, March 8, 2022 | NEW APPLICATION ENTERED |